Molecular clock modeling suggests that the biological onset of Barrett esophagus occurs more than 20 years before the ...
"We performed 3,177 EsoGuard tests in the first quarter of this year and this generated revenue of $1.3 million." (Chairman & CEO Lishan Aklog) "We also importantly strengthened our balance sheet with ...
Hosted on MSN
What you need to know about esophageal cancer
Why it’s dangerous: Esophageal cancer has a low survival rate due to late detection, with many cases diagnosed only after spreading to distant organs. Key risk factor: Barrett’s esophagus, caused by ...
Reward Picks Lucid Diagnostics (NASDAQ:LUCD) reported first-quarter 2026 EsoGuard test volume above its pre-Medicare target range, while management ...
Hosted on MSN
Living well with GERD and protecting your esophagus
Why it matters: Untreated GERD can cause long-term damage, including Barrett’s esophagus, which increases the risk of esophageal cancer. Everyday prevention: Avoid trigger foods, eat smaller meals, ...
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that its AdvanceAD-Tx test has been selected as the winner of the "Genomics ...
MedPage Today on MSN
Less Invasive Treatment Option for GERD May Offer Similar Results to Gold Standard
Participants who underwent cTIF procedure also experienced less dysphagia ...
Delivered Q1 2026 revenue of $83.7 millionQ1 2026 total test reports for our core revenue drivers (DecisionDx®-Melanoma, TissueCypher®) increased 36% over Q1 2025Raising ...
I recently read in your column that you test your patient’s magnesium levels when they have been on long-term proton-pump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results